Tuesday, April 26, 2016

BRIEF-FLX Bio announces $50 million series b financing

* Funds will be used to support further discovery and

development of company's phase 1 clinical compound, flx925

Source text for Eikon:

(Bengaluru Newsroom; +1 646 223 8780)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)